Cullinan Oncology Inc Stock - CGEM Share Price Today, News and Discussion

Cullinan Oncology, Inc. is a biopharmaceutical company engaged in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.

Sector:

Health Technology

Industry:

Pharmaceuticals Major

Employees:

31

Current Price	$11.77
Prev Close	$11.91
Open	$11.84
Dividend Yield	0.00%
50-Day Moving Average	$11.28
Beta	1.60
Avg. Volume	140,876.80
PE Ratio	5.30

52-Week High	$15.89
52-Week Low	$7.30
Market Capitalization	$538.74M
EPS	$2.22
Price to Book	0.88
Revenue Per Employee	N/A
Enterprise Value/EBITDA	0.22

No CGEM news at the moment.

CGEM Cullinan Oncology Inc

About

Feed

Fundamentals

News